1,324 employees at Anthropic, OpenAI, Meta, Google DeepMind, and SSI signed a July letter asking Washington to back a pre built international brake on frontier AI development.
1,324 employees at five frontier AI labs signed the same letter in July 2026. The Pacing the Frontier statement is a rare joint public document from labs that normally compete for talent, compute, and customers. The signatories are asking the U.S. government to back a pre-built international brake on frontier AI development if risks emerge. The letter's authors call this "an option to buy time," not a unilateral pause.
The signatories include Anthropic CEO Dario Amodei and OpenAI Chief Scientist Jakub Pachocki, per the Pacing the Frontier signatory index and Fortune's 2026-07-29 reporting. The breadth is the news. Five companies that compete for talent, compute, and customers have, for once, signed the same document.
The mechanism is not a self-imposed pause. The statement explicitly asks Washington to back an international effort that gives industry, government, and society "the option" to slow development if risks emerge. The word "option" is doing the structural work. A unilateral industry pause would not need a government backstop. An option to slow down only matters if it is internationally coordinated, pre-negotiated with regulators, and switchable in a crisis. The signatories are asking for the off-ramp before a crash forces one.
Fortune called the cross-lab signatory list "striking" given normal commercial rivalry. Midas Project founder Tyler Johnston, quoted by Fortune, called the cross-company agreement notable. The rivals are not signaling shared concern in the abstract. They are converging on the same procedural architecture: a pre-built regulatory mechanism that can be triggered if frontier AI crosses a line the labs would not voluntarily enforce on their own. Because the signatories are the same executives who would run any industry response, the firms asking for the option would also be the ones operating the switch.
The strongest test of the alternative read is whether these same labs are simultaneously opposing AI safety legislation in other venues. If they are, the industry-shaped-off-ramp reading collapses. No such opposition is in the current source basis. The letter's own "option to buy time" language supports the counterargument: that the coordination reflects genuine shared concern about catastrophic risk rather than competitive moat-building. The two reads can coexist.
The letter is a license-to-operate design exercise, not a unilateral pause. The next milestone is whether Washington, or any international body, takes the proposal up, and whether the signatories stay in the same room if the option is taken off the table.